Sign Up Today and Learn More About Tune Therapeutics Stock
Invest in or calculate the value of your shares in Tune Therapeutics or other pre-IPO companies through EquityZen's platform.
Tune Therapeutics Stock (TUTH)
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
About Tune Therapeutics Stock
Founded
2020
Headquarters
Seattle, WA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Tune Therapeutics Press Mentions
Stay in the know about the latest news on Tune Therapeutics
Seven biotechs to watch in the hepatitis B space
labiotech • Apr 23, 2025
Compositions, systems, and methods for reducing low-density lipoprotein through …
patents • Apr 02, 2025
Compositions, systems, and methods for lymphoid cell differentiation using …
patents • Apr 02, 2025
Compositions and methods for multiplexed activation and repression of t cell …
patents • Apr 02, 2025
Compositions and methods for modulating il-2 gene expression
patents • Apr 02, 2025
Tune Therapeutics Management
Leadership team at Tune Therapeutics
Co-Founder, President & CFO
Akira Matsuno
Co-Founder, Scientific Advisory Board
Fyodor Urnov
Join now and verify your accreditation status to gain access to:
- Tune Therapeutics Current Valuation
- Tune Therapeutics Stock Price
- Tune Therapeutics Management
- Available deals in Tune Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Tune Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Tune Therapeutics Revenue and Financials
- Tune Therapeutics Highlights
- Tune Therapeutics Business Model
- Tune Therapeutics Risk Factors
- Tune Therapeutics Research Report from SACRA Research
Trading Tune Therapeutics Stock
How to invest in Tune Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Tune Therapeutics through EquityZen funds. These investments are made available by existing Tune Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Tune Therapeutics stock?
Shareholders can sell their Tune Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
